Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: JANSSEN VACCINES & PREVENTION B.V.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2008-09-30 to 2023-09-30
Current total value of award: $69856435.9
Description: ADVANCED DEVELOPMENT OF MULTIVALENT FILOVIRUS (EBOLA AND MARBURG) HEMORRHAGIC FEVER VACCINES